Jonathan A. Tobert

Merck & Co., Inc., Rahway, NJ, USA (United States) ORCID: 0000-0001-7105-299X

3

h-index

3

Publications

1,135

Citations

Publications

3 shown

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

Jonathan A. Tobert

2003 Nature Reviews Drug Discovery 862 citations

The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day

Michael Davidson , Evan A. Stein , Carlos A. Dujovne +10 more

1997 The American Journal of Cardiology 169 citations

Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease A Reappraisal

Terje R. Pedersen , Jonathan A. Tobert

1996 Drug Safety 104 citations

Frequent Co-Authors

Michael Davidson

University of Nicosia

Evan A. Stein

Center for Clinical Research (United States)

Carlos A. Dujovne

Center for Clinical Research (United States)

Donald B. Hunninghake

Center for Clinical Research (United States)

Stuart Weiss

Center for Clinical Research (United States)

R. Knopp

Center for Clinical Research (United States)

Researcher Info

h-index: 3
Publications: 3
Citations: 1,135
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7105-299X

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.

Academic Output Over Time